Top compounds associated with response to TPSB2


Feature Type Standardized
Nominal ANOVA
mRNA sirolimus:bortezomib (250:1 mol/mol) CTRPv2 pan-cancer AAC -0.043 0.2
mRNA foretinib CTRPv2 pan-cancer AAC 0.045 0.2
mRNA isoliquiritigenin CTRPv2 pan-cancer AAC -0.081 0.2
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.044 0.2
mRNA PF-543 CTRPv2 pan-cancer AAC 0.047 0.2
mRNA purmorphamine CTRPv2 pan-cancer AAC 0.048 0.2
mRNA lapatinib gCSI pan-cancer AAC -0.067 0.2
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.063 0.2
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.04 0.2
mRNA BCL-LZH-4 CTRPv2 pan-cancer AAC 0.062 0.2
Download CSV